Korean exosuit maker Hurotics raises $18.6 million Series A
What's the deal? Hurotics, a South Korean wearable robotics startup, has raised a US$21M Series A led by Atinum InvestmentDealroom has a profile for this one. Try Dealroom →. The round lifts the company's total funding past US$28.1M.
Who's backing it? Most existing investors joined the follow-on, including Stonebridge VenturesDealroom has a profile for this one. Try Dealroom →, Industrial Bank of KoreaDealroom has a profile for this one. Try Dealroom →, Aju IB InvestmentDealroom has a profile for this one. Try Dealroom →, and Wonik Investment PartnersDealroom has a profile for this one. Try Dealroom →. New backers such as Mirae Asset Venture InvestmentDealroom has a profile for this one. Try Dealroom → also came in, alongside strategic investors DaewoongDealroom has a profile for this one. Try Dealroom →, NaverDealroom has a profile for this one. Try Dealroom →, and LotteDealroom has a profile for this one. Try Dealroom → from healthcare, retail, and IT.
What does it do? Founded in July 2022 by Chung-Ang University professor Giuk Lee, Hurotics builds soft exosuits — garment-like wearable robots that use cable-and-tendon drives to mimic muscle contraction. Its main product, H-Medi, is a medical gait-rehabilitation suit certified as a Class 2 combination medical device by South Korea's Ministry of Food and Drug Safety.
Lee led wearable robotics research on DARPA's "Warrior Web" project at Harvard's Wyss Institute. His paper on walking and running support was a 2019 cover article in Science .
What's the traction? Since commercial launch in September 2025, H-Medi has reached hospitals including Severance, Chung-Ang University, and Korea University. In June it was exported to the University of Illinois Chicago for stroke rehabilitation research and physical therapist training.
What's the money for? Hurotics will expand H-Medi's overseas certification and distribution, and develop and manufacture H-Care, a daily walking-assist robot. Longer term, it aims to build a wearable "physical AI" data platform offering personalised gait algorithms and risk prediction for muscle loss and falls.
Why the strategic backers? The company said the strategic investors were drawn to its path from hospital rehabilitation to everyday mobility support. It plans to work with them on hospital supply, distribution, overseas entry, and software development. "Our goal is to extend the recovery of movement that begins in hospitals into everyday health," said chief executive Giuk Lee.
The signal: At roughly $18.6 million, this ranks among the largest Series A rounds for a health startup in South Korea — above the 95th percentile across 298 such deals. The weight of healthcare, retail, and tech corporates on the cap table signals commercial conviction in medical exosuits moving beyond the clinic.
Read more: wowtale.net
Image credit: Generated with Gemini
